Japan
· Delayed Price · Currency is JPY SanBio Company Statistics
Total Valuation
SanBio Company has a market cap or net worth of JPY 136.68 billion. The enterprise value is 134.16 billion.
| Market Cap | 136.68B |
| Enterprise Value | 134.16B |
Important Dates
The last earnings date was Monday, March 17, 2025.
| Earnings Date | Mar 17, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SanBio Company has 72.01 million shares outstanding. The number of shares has increased by 5.43% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 72.01M |
| Shares Change (YoY) | +5.43% |
| Shares Change (QoQ) | +1.64% |
| Owned by Insiders (%) | 26.83% |
| Owned by Institutions (%) | -4.69% |
| Float | 51.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 77.53 |
| P/TBV Ratio | 79.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -46.54 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -37.18 |
Financial Position
The company has a current ratio of 4.56, with a Debt / Equity ratio of 0.23.
| Current Ratio | 4.56 |
| Quick Ratio | 3.99 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.11 |
| Interest Coverage | -422.86 |
Financial Efficiency
Return on equity (ROE) is -126.57% and return on invested capital (ROIC) is -78.24%.
| Return on Equity (ROE) | -126.57% |
| Return on Assets (ROA) | -51.74% |
| Return on Invested Capital (ROIC) | -78.24% |
| Return on Capital Employed (ROCE) | -129.49% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -99.41M |
| Employee Count | 29 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +355.16% in the last 52 weeks. The beta is -0.08, so SanBio Company's price volatility has been lower than the market average.
| Beta (5Y) | -0.08 |
| 52-Week Price Change | +355.16% |
| 50-Day Moving Average | 1,461.38 |
| 200-Day Moving Average | 1,088.38 |
| Relative Strength Index (RSI) | 53.79 |
| Average Volume (20 Days) | 6,028,925 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.52B |
| Pretax Income | -3.01B |
| Net Income | -2.88B |
| EBITDA | -3.51B |
| EBIT | -3.52B |
| Earnings Per Share (EPS) | -41.86 |
Balance Sheet
The company has 2.92 billion in cash and 397.00 million in debt, giving a net cash position of 2.52 billion or 35.05 per share.
| Cash & Cash Equivalents | 2.92B |
| Total Debt | 397.00M |
| Net Cash | 2.52B |
| Net Cash Per Share | 35.05 |
| Equity (Book Value) | 1.76B |
| Book Value Per Share | 24.86 |
| Working Capital | 2.60B |
Cash Flow
In the last 12 months, operating cash flow was -3.60 billion and capital expenditures -4.89 million, giving a free cash flow of -3.61 billion.
| Operating Cash Flow | -3.60B |
| Capital Expenditures | -4.89M |
| Free Cash Flow | -3.61B |
| FCF Per Share | -50.10 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SanBio Company does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.43% |
| Shareholder Yield | -5.43% |
| Earnings Yield | -2.11% |
| FCF Yield | -2.64% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |